Keywords: |
controlled study; human cell; flow cytometry; phenotype; cell structure; multiple myeloma; genotype; cytotoxicity; tumor cells, cultured; b cell lymphoma; lymphoma, b-cell; immunotherapy; immunophenotyping; ganglioside gm1; ganglioside gm3; acute lymphocytic leukemia; chronic lymphatic leukemia; glycoprotein; burkitt lymphoma; ganglioside gd3; ganglioside gm2; b cell leukemia; gangliosides; ganglioside; lymphoma, large-cell, diffuse; histiocytic lymphoma; chromatography, thin layer; humans; human; priority journal; article; leukemia, b-cell, chronic; leukemia, b-cell, acute; ganglioside expression; b-cell neoplasms; high performance thin layer chromatography; lymphoma, undifferentiated
|